✦ LIBER ✦

PCV99 PHARMACOECONOMICS OF DIRECT RENIN INGIBITOR ALISKIREN IN HYPERTENSION TREATMENT OF PATIENTS WITH TYPE-2 DIABETES AND NEPHROPATHY

✍ Scribed by AV Rudakova

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Renoprotective effect of aliskiren monot

✍ Hamed, Amin T.; Taha, Mohammed M.; Nasser, Luay M. 📂 Article 📅 2013 🏛 Egypts Presidential Specialized Council for Educat 🌐 English ⚖ 563 KB

PUK19 ECONOMIC EVALUATION OF ALISKIREN I

✍ Nevarez, A; García-Contreras, F; Olvera, K 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PCV72 COST-EFFECTIVENESS ANALYSIS OF ADD

✍ P Kutscherauer; R Kodym; D Bartaskova 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

Prevalence of nephropathy in Greek patie

✍ Aris D. Efstratopoulos; Sofia M. Voyaki; Athanasios Baltas; Sofia Siasiakou; Vas 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 45 KB

Efficacy and safety of the direct renin

✍ Uresin, Yagiz; Taylor, Addison A; Kilo, Charles; Tschöpe, Diethelm; Santonastaso 📂 Article 📅 2007 🏛 SAGE Publications 🌐 English ⚖ 184 KB

PCV47 DIRECT MEDICAL COSTS FOR TREATMENT

✍ P Berto; G Cremonesi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB